1) drug-loaded nanospheres
载药纳米微球
1.
Probing the inhibitory effect of 5-Fu/Cs drug-loaded nanospheres to human hepatoma cells with atomic force microscopy
壳聚糖载药纳米微球对人肝癌细胞的杀伤作用及AFM探测
2.
Preparation and character of 5-fluorouracil/chitosan drug-loaded nanospheres
5-氟尿嘧啶/壳聚糖载药纳米微球的制备及性能
2) drug nanospheres
纳米载药微球
1.
Magnetic drug nanospheres consist of magnetic nanoparticles, drug and framework materials, it could be selectively localized to the tragetsite of turmor by external magnetic field and thus it achieve high drug concentration to the cell and reduce undesirable toxic effects.
磁性纳米载药微球是由超顺磁性纳米粒子,抗癌药物和骨架材料共同构成,在外加磁场作用下,选择性的到达肿瘤区域释放药物,使药物在肿瘤组织的细胞水平发挥作用,而对正常细胞无太大影响,在治疗恶性肿瘤方面表现出十分广阔的前景。
3) drug loaded nanoparticle
载药纳米微粒
1.
In recent years,the application basic research of drug loaded nanoparticle develops rapidly,and.
载药纳米微粒是纳米技术与现代医药学结合的产物 ,是一种新型的药物输送载体。
4) Sub-microparticle
载药亚微米球
5) nanosphere
纳米微球
1.
Studies on cetyl-chitosan nanosphere as carriers for paclitaxel;
十六烷基壳聚糖纳米微球负载紫杉醇的研究
2.
Preparation and Characterization of PS/TiO2 Composite Nanospheres;
PS/TiO_2复合纳米微球的制备和结构表征
3.
Study on Encapsulation of Plasmid DNA in Poly(Ethylene Glycol)-Poly(Benzyl L-Glutamate) Copolymer Nanospheres and its Characteristics in Vitro;
转基因载体聚乙二醇-聚谷氨酸纳米微球的制备
6) nanoparticle
纳米微球
1.
The Preparation of Berbamine-paclitaxel Nanoparticles and Evaluation of Its Synergistic Antitumor Effect in Vitro
小檗胺与紫杉醇纳米微球的构建及其体外协同抑瘤效应评价
2.
Preparation and evaluation of alginate nanoparticle simultaneous delivery of doxorubicin and Tf antibody
人转铁蛋白修饰海藻酸钠载阿霉素纳米微球的制备与表征
3.
The new approach for the preparation of the MAF/PCL micelles by self-assembly of a core-shell structure in aqueous solution with PFA chain fragment and PCL as the core and PAA chain fragment in MAF to form complex nanosize micelles and can be further crosslinked to get core-shell structure nanoparticles.
将MAF与可生物降解均聚物聚己内酯(PCL)在水溶液中进行自组装,形成以MAF中PFA链段与PCL为核、MAF中PAA链段为壳的核壳结构复合纳米胶束,进一步对PAA壳进行化学交联,最终得到具有核壳结构的复合纳米微球。
补充资料:可降解淀粉微球和生物降解白蛋白微球阻滞法
可降解淀粉微球和生物降解白蛋白微球阻滞法
介入放射学技术。介入性局部化疗之前,把二者注入靶动脉,可暂时减少动脉血流,再行化疗药物灌注,以减少血液冲刷,保持局部化疗药物浓度的技术。与其他中期和长期栓塞微球不同,DSM和BAM仅造成数十分钟的血流量减少,待其被降解后血流可恢复至以前水平。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条